America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the TD Cowen ...

The Nation has won overall best at the Ninth Open Forum on Agricultural Biotechnology (OFAB) Nigeria Media Awards. The ...

Nautilus Biotechnolgy ( ($NAUT) ) has shared an announcement. On November 3, 2025, Nautilus Biotechnology, Inc. announced that it has regained ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Viagen Pets and Equine is a biotechnology company that will produce genetic twins of customers' pets and livestock. But its conservation efforts are what attracted Colossal.

Amgen Inc. raised its full-year guidance after third-quarter results beat expectations, a positive sign in light of hurdles ...

The apparel industry accounts for 10% of greenhouse gas emissions. Biotechs are working on reengineering natural products to make more sustainable textiles, which are gaining traction.

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the completion of enrollment for ECLIPSE 1, a Phase 3 trial evaluating the safety and efficacy of the combination of tobevibart and elebsiran in ...